Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialise branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 125 clients worldwide and is headquartered from a 12,000m2 facility in Salisbury, South Australia.
A technology driven company, Mayne Pharma has a significant product portfolio and pipeline, global reach through distribution partners in Australia, North America, Europe and Asia and two product development and manufacturing facilities based in Salisbury, Australia and Greenville, North Carolina, USA with expertise in formulating complex oral dose forms including highly potent compounds, controlled substances, modified release products and inherently unstable compounds. The business is supported by over 600 staff globally with more than 180 scientists employed.
Updated: September 11, 2016
Categories: Healthcare & Medical, SA Owned and Operated Business, Manufacturing and Wholesale
Name of Author
Like this business? Share it today.
